MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Watch List: Layoffs of 10% or More, Strategic Corporate Review, Delisting, Regulatory, Financial and/or Legal Issues
Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC)*
Organization & Developments: Cyclacel Pharmaceuticals
Parents
Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC)*
Children
*Cyclacel is a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious diseases
*Cyclacel Pharmaceuticals Inc. is a biotechnology firm developing cancer drugs and treatments.
2021: Checking In On Cyclacel Pharmaceuticals
2022: Cyclacel Pharmaceuticals (CYCC) Investor Presentation - Slideshow_ seekingalpha.com
2024: Cash-strapped Cyclacel cuts costs as it searches for financial lifeline
Jumps
*Key People: Cyclacel Pharmaceuticals
Finance & Acquisitions: Cyclacel Pharmaceuticals